Lexeo Therapeutics Inc. C...
5.46
-0.34 (-5.86%)
At close: Jan 15, 2025, 3:59 PM
5.49
0.55%
After-hours Jan 15, 2025, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 121.47M 77.33M 135.86M 29.37M
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a 3.25M n/a n/a
Other Long-Term Assets 3.25M 3.25M 2.00K 2.50K
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 2.83M 2.71M 824.00K 33.57K
Total Current Assets 124.29M 80.05M 136.68M 29.41M
Property-Plant & Equipment 12.26M 13.78M 174.00K n/a
Goodwill & Intangibles n/a -7.49M n/a n/a
Total Long-Term Assets 15.51M 17.03M 176.00K 2.50K
Total Assets 139.81M 97.08M 136.86M 29.41M
Account Payables 3.79M 2.68M 3.06M 44.32K
Deferred Revenue n/a 8.60M 46.00K 140.38K
Short-Term Debt 2.60M 2.83M n/a n/a
Other Current Liabilities 10.68M 8.33M 3.81M 474.71K
Total Current Liabilities 17.24M 14.35M 7.45M 697.72K
Long-Term Debt 9.03M 10.65M n/a n/a
Other Long-Term Liabilities n/a 185.03M 185.01M 34.25M
Total Long-Term Liabilities 9.03M 195.68M 185.01M 34.25M
Total Liabilities 26.27M 210.03M 192.46M 34.95M
Total Debt 11.64M 13.48M n/a 3.01M
Common Stock 3.00K 2.00K 2.00K 1.60K
Retained Earnings -181.84M -115.45M -56.17M -5.55M
Comprehensive Income n/a -185.03M -185.01M -31.24M
Shareholders Equity 113.53M -112.95M -55.60M -5.54M
Total Investments 3.25M 3.25M n/a n/a